Earnings Feed
Start Free
Home/Filings/4/0001562180-17-003381
4//SEC Filing

Gavin Robert M. 4

Accession 0001562180-17-003381

CIK 0000842023other
View on SEC.govCompany Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 4:57 PM ET

Size

24.8 KB

Accession

0001562180-17-003381

Insider Transaction Report

Form 4
Period: 2017-10-26
BIO-TECHNE CorpTECH
Gavin Robert M.
Sen. VP Protein Platforms
Transactions
  • Award

    Stock Options (Right to buy)

    2017-10-26+10,742→ 10,742 total
    Exercise: $125.05Exp: 2024-08-09→ Common Stock (10,742 underlying)
  • Award

    Stock Options (Right to buy)

    2017-10-26+14,323→ 14,323 total
    Exercise: $125.05Exp: 2024-08-09→ Common Stock (14,323 underlying)
  • Award

    Restricted Stock Units

    2017-10-26+1,949→ 1,949 total
    → Common Stock (1,949 underlying)
Holdings

  • Stock Options (Right to buy)

    Exercise: $106.59Exp: 2023-08-18→ Common Stock (17,371 underlying)
    17,371

  • Stock Options (Right to buy)

    Exercise: $93.32Exp: 2021-07-31→ Common Stock (16,667 underlying)
    16,667

  • Restricted Stock Units

    → Common Stock (1,500 underlying)
    1,500

  • Restricted Stock Units

    → Common Stock (2,111 underlying)
    2,111

  • Stock Option (Right to Buy)

    Exercise: $108.49Exp: 2022-08-07→ Common Stock (12,500 underlying)
    12,500

  • Stock Option (Right to Buy)

    Exercise: $108.49Exp: 2022-08-07→ Common Stock (9,375 underlying)
    9,375

  • Stock Option (Right to Buy)

    Exercise: $93.32Exp: 2021-07-31→ Common Stock (10,000 underlying)
    10,000

  • Stock Option (Right to Buy)

    Exercise: $90.25Exp: 2021-11-30→ Common Stock (5,000 underlying)
    5,000

  • Common Stock

    1,667

  • Stock Options (Right to buy)

    Exercise: $106.59Exp: 2023-08-18→ Common Stock (13,028 underlying)
    13,028
Footnotes (11)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F10]Vests 4,343 shares on each 8/18/2017, 8/18/2018 and 8/18/2019 and 4,342 shares on 8/18/2020
  • [F11]Fully exercisable
  • [F2]Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F3]Vests 3,580 shares on 8/9/2018 and 3,581 shares each on 8/9/2019, 8/9/2020, 8/9/2021.
  • [F4]Each restricted stock unit represents a contingent right to receive one shares of Bio-Techne common stock.
  • [F5]Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F6]Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F7]3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
  • [F8]2,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
  • [F9]1,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.

Documents

2 files

Issuer

BIO-TECHNE Corp

CIK 0000842023

→
Entity typeother

Related Parties

1
  • filerCIK 0001608023

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:57 PM ET
Size
24.8 KB
View on SEC.gov